SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS shares fell sharply on heavy volume without a clear company-specific update, as traders debated whether broader biotech weakness and options-expiration dynamics contributed to the selloff. The main focus remains the pending REGAL Phase 3 milestone and data, with bullish holders viewing the delay in reaching the 80th event as potentially encouraging while skeptics cite the prolonged quiet period as a source of concern.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Reports of plague and respiratory-virus outbreaks have prompted speculation that Arcturuss self-amplifying mRNA platform could be relevant to future vaccines, with some traders pointing to its COVID-vaccine technology and discussing a possible plague vaccine. No new ARCT program or outbreak-related deal is confirmed, and the discussion also includes frustration over the share-price decline.

iShares Trust - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

A rebound in long Treasuries as yields eased has drawn attention to TLT, with traders pointing to risk-off demand, Fed-rate expectations and possible short covering even as inflation remains a concern. The community is split between those seeing a lasting bond recovery and those viewing it as a temporary bounce, with sticky inflation and further rate hikes cited as risks.

Robinhood GLD is a tokenized representation of SPDR Gold Shares (GLD) common stock, issued on Robinhood Chain, Robinhood's own blockchain built to bring tokenized real-world assets on-chain. Each token is designed to track the price of the underlying GLD share, giving holders on-chain price exposure to SPDR Gold Shares's stock. The token is freely transferable and composable across the Robinhood Chain ecosystem. It's part of Robinhood's broader initiative to expand access to tokenized U.S. equities via blockchain technology, alongside a wider lineup of tokenized stock tokens launching on the same network.

GoldCoin

Golds sharp correction amid hotter inflation, rising Treasury yields and a stronger dollar is the main focus, as traders debate whether the pressure will persist or the pullback has created a buying opportunity. Some also point to easing yields and dollar weakness as support for a recovery in precious metals.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Rapidly delayed delivery estimates after iPhone Duo preorders sold out have fueled attention, with bulls citing strong demand and skeptics arguing that limited launch inventory may explain the sellout. Traders also highlight Apples relative resilience during the AI and chip-stock selloff, while debating whether its valuation is justified.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeaves steep selloff is centered on fears that its debt-funded AI data-center expansion, rising borrowing costs and cash burn could threaten its ability to service debt, amid a broader retreat from AI infrastructure stocks; reported founder share sales have added to the pressure. Traders are split between viewing the decline as an overreaction given AI demand and Nvidias support, and worrying that leverage and financing risks could overwhelm the business.

Grayscale Ethereum Trust (ETH) operates as open-end investment company. Its investment objective is for the shares to reflect the value of ETH held by the trust. The company was founded on December 13, 2017 and is headquartered in Stamford, CT.

Grayscale Ethereum Staking Mini ETF - Common units of fractional undivided beneficial interest

Grayscale Ethereum Mini Trust

Ethereums sharp rebound and breakout are driving attention, with bullish traders citing renewed crypto momentum and institutional adoption; others remain cautious about volatility, thin volume, and overleveraged positions.

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Emergent Biosolutions Inc

Emergent BioSolutions CFO announced plans to retire at the end of 2026, with the company naming its treasurer as interim successor. Traders are debating whether the planned transition is routine or signals deeper financial or accounting concerns, amid a sharp share-price decline.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is drawing attention for volatile price swings and perceived resilience versus Bitcoin, with bulls watching for a breakout and citing the planned CashVM/Layla upgrade as a potential catalyst. Skeptics counter that BCHs utility and momentum remain weak.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MLTXs prolonged selloff has traders weighing disappointment with IZAR-1 results and doubts about managements plan to commercialize sonelokimab independently against the companys filed FDA application for hidradenitis suppurativa. Discussion remains split between concerns about regulatory and commercial risks and bullish views that the drug, cash balance, and broader pipeline support the long-term case.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Target Group, Inc. is an investment holding company, engaged in the cultivation, processing and distribution of curated cannabis products for the adult-use medical and recreational cannabis market. It offers cannabis flower pods and extract pods for vaporizer use, cannabis pre-rolls, K-Cup infused coffee and tea pods, infused cannabis beverages, infused cannabis edibles, and infused topical and cannabidiol wellness products. The company was founded on July 2, 2013 and is headquartered in Hamilton, Canada.

Target Group Inc

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$0.0007
Prev Close	$0.0007
Open	$0.0008
Dividend Yield	0.00%
50-Day Moving Average	$0.0009
Beta	0.38
Avg. Volume	303,226.05
PE Ratio	-0.23

52-Week High	$0.003
52-Week Low	$0.0005
Market Capitalization	$431,918.00
EPS (Annual)	-$0.0022
Price to Book	-0.05
Revenue Per Employee	$97,041.40

Feed

News

Sentiment

Fundamentals

Info

CBDY Fundamentals